shRNA-mediated inhibition of expression of alpha-1. 6-fucosyltransferase

Details for Australian Patent Application No. 2007338403 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Burtscher, Helmut; Beuger, Vincent; Klein, Christian

Agent Spruson & Ferguson

Pub. Number AU-B-2007338403

PCT Pub. Number WO2008/077547

Priority 06026653.3 22.12.06 EP

Filing date 19 December 2007

Wipo publication date 3 July 2008

Acceptance publication date 6 September 2012

International Classifications

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/10 Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12N 15/85 Mutation or genetic engineering - for animal cells

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/077547 Priority application(s): WO2008/077547

6 September 2012 Application Accepted

  Published as AU-B-2007338403

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338404-Pyrimidyl derivatives as protein kinase inhibitors

2007338402-Antibodies against insulin-like growth factor I receptor and uses thereof